Denosumab for Smoldering Multiple Myeloma
Clinical trial NCT03839459 · COMPLETED
Trial details
- NCT number
- NCT03839459
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2022-09-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.